Clinical Trial Detail

NCT ID NCT03564288
Title Study to Find a Safe and Effective Dose of SKI-G-801 in the Treatment of Patients With Acute Myeloid Leukemia (AML)
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Oscotec Inc.
Indications

acute myeloid leukemia

Therapies

SKI-G-801

Age Groups: adult senior

No variant requirements are available.